Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 12-2022 | 06-2022 | 12-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,617 | -15,397 | -4,513 | -26,657 | -17,594 |
| Depreciation Amortization | 55 | 51 | 5 | 141 | 3 |
| Other Working Capital | -5,188 | -1,164 | -1,820 | -773 | -119 |
| Other Operating Activity | 2,358 | -3,105 | -5,585 | 5,527 | 4,572 |
| Operating Cash Flow | $-11,392 | $-19,615 | $-11,913 | $-21,762 | $-13,138 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | N/A | -22 | -21 |
| Other Investing Activity | -254 | -3,996 | -3,483 | 152 | 0 |
| Investing Cash Flow | $-254 | $-3,996 | $-3,483 | $130 | $-21 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -37 | -55 | 0 | -23 | -277 |
| Financing Cash Flow | $-37 | $-55 | $N/A | $-23 | $-277 |
| Exchange Rate Effect | 158 | -398 | 247 | -1,983 | N/A |
| Beginning Cash Position | 18,122 | 42,186 | 42,186 | 65,824 | 67,398 |
| End Cash Position | 6,597 | 18,122 | 26,543 | 42,186 | 53,962 |
| Net Cash Flow | $-11,525 | $-24,064 | $-15,643 | $-23,638 | $-13,436 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,392 | -19,615 | -11,913 | -21,762 | -13,138 |
| Free Cash Flow | -11,392 | -19,615 | -11,913 | -21,762 | -13,138 |